CO2017004442A2 - Dispositivo de inhalación - Google Patents
Dispositivo de inhalaciónInfo
- Publication number
- CO2017004442A2 CO2017004442A2 CONC2017/0004442A CO2017004442A CO2017004442A2 CO 2017004442 A2 CO2017004442 A2 CO 2017004442A2 CO 2017004442 A CO2017004442 A CO 2017004442A CO 2017004442 A2 CO2017004442 A2 CO 2017004442A2
- Authority
- CO
- Colombia
- Prior art keywords
- inhalation device
- sulfomethylated polymyxin
- patient
- requires
- pulmonary
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/001—Particle size control
- A61M11/003—Particle size control by passing the aerosol trough sieves or filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Manipulator (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462059748P | 2014-10-03 | 2014-10-03 | |
PCT/EP2015/072736 WO2016050933A1 (en) | 2014-10-03 | 2015-10-01 | Inhalation device |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2017004442A2 true CO2017004442A2 (es) | 2017-09-29 |
Family
ID=54249495
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2017/0004442A CO2017004442A2 (es) | 2014-10-03 | 2017-05-02 | Dispositivo de inhalación |
Country Status (26)
Country | Link |
---|---|
US (1) | US11033602B2 (sl) |
EP (2) | EP3520777B1 (sl) |
JP (1) | JP6626890B2 (sl) |
KR (1) | KR102494511B1 (sl) |
CN (1) | CN106999542B (sl) |
AU (1) | AU2015326847B2 (sl) |
BR (1) | BR112017006816A2 (sl) |
CA (1) | CA2962120C (sl) |
CO (1) | CO2017004442A2 (sl) |
CY (1) | CY1121803T1 (sl) |
DK (1) | DK3200762T3 (sl) |
ES (1) | ES2721401T3 (sl) |
HR (1) | HRP20190747T1 (sl) |
HU (1) | HUE044289T2 (sl) |
IL (1) | IL251480B (sl) |
LT (1) | LT3200762T (sl) |
MX (1) | MX2017004175A (sl) |
PH (1) | PH12017500538A1 (sl) |
PL (1) | PL3200762T3 (sl) |
PT (1) | PT3200762T (sl) |
RS (1) | RS58792B1 (sl) |
RU (1) | RU2702335C2 (sl) |
SG (1) | SG11201702666SA (sl) |
SI (1) | SI3200762T1 (sl) |
TR (1) | TR201906108T4 (sl) |
WO (1) | WO2016050933A1 (sl) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL3200827T3 (pl) | 2014-10-03 | 2020-12-14 | Xellia Pharmaceuticals Aps | Kompozycje |
CN112546030A (zh) * | 2019-09-26 | 2021-03-26 | 盈科瑞(天津)创新医药研究有限公司 | 一种吸入用多粘菌素e甲磺酸钠溶液及其制备方法 |
US20230052317A1 (en) * | 2021-08-05 | 2023-02-16 | Zambon S.P.A. | Treatment of non-cystic fibrosis bronchiectasis |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1062895A (en) | 1962-12-13 | 1967-03-22 | Wellcome Found | Sulphomethyl derivatives of polymxin |
FR1586834A (sl) | 1968-02-12 | 1970-03-06 | ||
DE1906699A1 (de) | 1968-02-12 | 1970-02-05 | Pfizer | Neue Polymyxinderivate und Verfahren zu deren Herstellung |
AU611030B2 (en) | 1988-04-07 | 1991-05-30 | Edward Shanbrom | Non-thrombogenic intravascular time release catheter |
SE9201246D0 (sv) | 1992-04-21 | 1992-04-21 | Kabi Pharmacia Ab | Injection cartridge arrangement |
NL9401260A (nl) | 1993-11-12 | 1995-06-01 | Cornelis Johannes Maria Van Ri | Membraan voor microfiltratie, ultrafiltratie, gasscheiding en katalyse, werkwijze ter vervaardiging van een dergelijk membraan, mal ter vervaardiging van een dergelijk membraan, alsmede diverse scheidingssystemen omvattende een dergelijk membraan. |
WO1998020836A2 (en) | 1996-11-15 | 1998-05-22 | Pathogenesis Corporation | Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections |
US5767068A (en) * | 1997-02-13 | 1998-06-16 | Pathogenesis Corporation | Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections |
PT1320355E (pt) | 2001-05-18 | 2006-08-31 | Chiron Corp | Sistema para administracao de uma formulacao de tobramicina |
US20040022740A1 (en) | 2001-07-10 | 2004-02-05 | Baker William R. | Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
SI1340506T1 (sl) | 2002-03-01 | 2007-04-30 | Chiesi Farma Spa | Sestavki, ki vsebujejo pljucne surfaktante in polimiksin z izboljsanimi povrsinskimi lastnostmi |
WO2008025560A1 (en) * | 2006-09-01 | 2008-03-06 | Pari Pharma Gmbh | Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy |
US20080066739A1 (en) * | 2006-09-20 | 2008-03-20 | Lemahieu Edward | Methods and systems of delivering medication via inhalation |
US8329645B2 (en) * | 2008-02-08 | 2012-12-11 | Northern Antibiotics Ltd. | Polymyxin derivatives and uses thereof |
DE102008030267B3 (de) | 2008-06-19 | 2010-01-28 | Arzneimittel Gmbh Apotheker Vetter & Co. Ravensburg | Verfahren zum Befüllen von Doppelkammersystemen in vorsterilisierbaren Trägersystemen und vorsterilisierbares Trägersystem |
WO2011043712A1 (en) | 2009-10-08 | 2011-04-14 | Shl Group Ab | Metered liquid droplet inhaler |
AU2010311759B2 (en) | 2009-10-30 | 2015-09-24 | Xellia Pharmaceuticals Aps | Method for purification of colistin and purified colistin components |
WO2012168820A1 (en) | 2011-06-08 | 2012-12-13 | Pfizer Inc. | Polymyxin derivatives useful as antibacterial agents |
CN102531955B (zh) | 2011-09-16 | 2014-02-19 | 浙江众益制药股份有限公司 | 奥沙拉秦钠的制备方法和甲磺化反应的后处理方法 |
KR20150107793A (ko) | 2013-01-11 | 2015-09-23 | 셀리아 파마슈티칼즈 에이피에스 | 폴리믹신, 조성물, 제조 방법 및 사용 방법 |
TW201522364A (zh) | 2013-06-07 | 2015-06-16 | Xellia Pharmaceuticals Aps | 黏菌素甲磺酸鈉(cms)之定性方法 |
BR112017000228A2 (pt) | 2014-07-09 | 2017-10-31 | Xellia Pharmaceuticals Aps | polimixinas de baixa substituição e suas composições. |
PL3200827T3 (pl) * | 2014-10-03 | 2020-12-14 | Xellia Pharmaceuticals Aps | Kompozycje |
-
2015
- 2015-10-01 US US15/516,286 patent/US11033602B2/en active Active
- 2015-10-01 JP JP2017517048A patent/JP6626890B2/ja active Active
- 2015-10-01 SI SI201530718T patent/SI3200762T1/sl unknown
- 2015-10-01 MX MX2017004175A patent/MX2017004175A/es active IP Right Grant
- 2015-10-01 LT LTEP15774606.6T patent/LT3200762T/lt unknown
- 2015-10-01 BR BR112017006816A patent/BR112017006816A2/pt not_active Application Discontinuation
- 2015-10-01 WO PCT/EP2015/072736 patent/WO2016050933A1/en active Application Filing
- 2015-10-01 KR KR1020177011791A patent/KR102494511B1/ko active IP Right Grant
- 2015-10-01 RU RU2017114144A patent/RU2702335C2/ru active
- 2015-10-01 CA CA2962120A patent/CA2962120C/en active Active
- 2015-10-01 EP EP19163697.6A patent/EP3520777B1/en active Active
- 2015-10-01 DK DK15774606.6T patent/DK3200762T3/da active
- 2015-10-01 CN CN201580065903.0A patent/CN106999542B/zh active Active
- 2015-10-01 PT PT15774606T patent/PT3200762T/pt unknown
- 2015-10-01 EP EP15774606.6A patent/EP3200762B1/en active Active
- 2015-10-01 RS RS20190509A patent/RS58792B1/sr unknown
- 2015-10-01 HU HUE15774606 patent/HUE044289T2/hu unknown
- 2015-10-01 PL PL15774606T patent/PL3200762T3/pl unknown
- 2015-10-01 ES ES15774606T patent/ES2721401T3/es active Active
- 2015-10-01 TR TR2019/06108T patent/TR201906108T4/tr unknown
- 2015-10-01 SG SG11201702666SA patent/SG11201702666SA/en unknown
- 2015-10-01 AU AU2015326847A patent/AU2015326847B2/en active Active
-
2017
- 2017-03-23 PH PH12017500538A patent/PH12017500538A1/en unknown
- 2017-03-30 IL IL251480A patent/IL251480B/en active IP Right Grant
- 2017-05-02 CO CONC2017/0004442A patent/CO2017004442A2/es unknown
-
2019
- 2019-04-22 CY CY20191100440T patent/CY1121803T1/el unknown
- 2019-04-23 HR HRP20190747TT patent/HRP20190747T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4238597A3 (en) | The invention relates to a drug delivery device | |
CY1121928T1 (el) | Φαρμακευτικη συνθεση υδροχλωρικης s-κεταμινης | |
CL2016002517A1 (es) | Uso de ácido r-2-4-2-etoxi-3-4-trifluormetilfenoxipropil-tio-2-metilfenoxi acético o una sal del mismo en la fabricación de un medicamento para tratar una condición que es una enfermedad de hígado graso no alcohólico o esteatohepatitis no alcohólica. | |
MX2021006035A (es) | Formulaciones cannabinoides estables. | |
MX2017000055A (es) | Cartucho de dosis de farmaco para un dispositivo inhalador. | |
MA40630A (fr) | Dispositif d'administration d'un agent thérapeutique muni d'une canule et d'une aiguille pouvant avancer. | |
CL2017000156A1 (es) | Procedimientos para el tratamiento de paramixovirus. | |
BR112018011496A2 (pt) | sistema para distribuição de nicotina em pó | |
MX2016015179A (es) | Una formulación líquida que comprende nicotina para administracion en aerosol. | |
CL2014002808A1 (es) | Dispositivo de inhalacion plegable para usar con un dispensador de inhalador de dosis medida, dicho dispositivo comprende un miembro de la extremidad de salida incluyendo una boquilla, un miembro de la extremidad de entrada incluyendo un orificio de entrada, y un miembro de manguito tubular; metodo para administrar una dosis de un medicamento; metodo para formar un dispositivo de inhalacion plegable. | |
CL2008003447A1 (es) | Dispositivo dosificador, para aparato inhalador, para inhalar una sustancia pulverulenta del tipo medicinal contenida en una camara de almacenamiento, con una varilla dosififadora desplazable y un embolo provisto de lenguetas que se extienden hasta una camara dosificadora formada de dicha varilla | |
MX2016005395A (es) | Formulacion estable de insulina glulisina. | |
CL2013003497A1 (es) | Producto farmacéutico de combinación en forma de polvo seco para administración por medio de un inhalador que comprende una sal de umeclidinio de un grupo definido y 100 mcg/dosis de furoato de fluticasona, sin otros activos adicionales; uso para el tratamiento de enfermedades inflamatorias o del aparato respiratorio. | |
CO2017004442A2 (es) | Dispositivo de inhalación | |
ECSP16084317A (es) | Formulaciones farmacéuticas, procesos para la preparación y métodos de uso | |
AR100860A1 (es) | Dispositivo inhalador accionado por la respiración | |
MX2017004546A (es) | Carcasa y dispositivo de administracion de farmacos. | |
ECSP16086247A (es) | (s)-pirlindole y sus sales farmacéuticamente aceptables para uso en medicina | |
MX2018012406A (es) | Dispositivo de inyeccion accionado para suministrar formulaciones liquidas multiples, incluyendo vacunas. | |
CO2017004303A2 (es) | Una solución acuosa que comprende polimimina sulfometilada y un cartucho | |
CO2017001903A2 (es) | Entrega coordinada del tratamiento del epoc | |
ECSP16086232A (es) | (r) -pirlindole y sus sales farmacéuticamente aceptables para uso en medicina | |
AR102192A1 (es) | Pieza de inserción y dispositivo de administración de fármacos con la misma | |
CL2016000397A1 (es) | Tratamiento contra el cáncer | |
EP2668952A3 (en) | Aqueous formulations of bisphosphonates, vitamin D and benzyl alcohol suitable for subcutaneous or intramuscular use |